Professor and Chair Department of Radiology Baylor College of Medicine
Radiology
Dr. Eric M. Rohren, MD
|
|
Give Review
Eric Rohren is an expert in the field of Radiology. He researched medicine at Mayo Medical School. Mayo Medical School is ranked 27 in research and 42 in primary care medicine He over the years received 1 awards: "Top Doctors:SE Texas". Eric M. Rohren, MD is a published doctor. He published 71 publications, including: 'Polymorphisms in pockets of major histocompatibility complex class I molecules influence peptide preference.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study.
- Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
- Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy.
- Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
- American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MRI: Brain.
- The acetabular fossa hot spot on (18) F-FDG PET/CT: epidemiology, natural history, and proposed etiology.
- Correlation of PUV and SUV in the extremities while using PEM as a high-resolution positron emission scanner.
- Measuring the Extent of Total Thyroidectomy for Differentiated Thyroid Carcinoma Using Radioactive Iodine Imaging: Relationship With Serum Thyroglobulin and Clinical O...
- SNMMI Comment on ASCO 2013 "Choosing Wisely" Recommendation on Use of PET/CT in Recurrent Cancer Surveillance.
- Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer.
- Prostate cancer, version 1.2014.
- Is imaging the extremities with PEM feasible? A novel application for a high-resolution positron emission scanner.
- (18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy.
- Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma.
- A software tool for stitching two PET/CT body segments into a single whole-body image set.
- Fast dixon whole-body MRI for detecting distant cancer metastasis: A preliminary clinical study.
- Investigating the limit of detectability of a positron emission mammography device: A phantom study.
- Implementation of Automated Tube Current Modulation in PET/CT: Prospective Selection of a Noise Index and Retrospective Patient Analysis to Ensure Image Quality.
- PET/CT in a Patient With Adenoma Malignum of the Uterine Cervix.
- Positron emission tomography-computed tomography reporting in radiation therapy planning and response assessment.
- 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
- Average CT in PET studies of colorectal cancer patients with metastasis in the liver and esophageal cancer patients.
- Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy.
- Hepatic radiation injury mimicking a metastasis on positron-emission tomography/computed tomography in a patient with esophageal carcinoma.
- 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma.
- Positron emission tomography-CT imaging in guiding musculoskeletal biopsy.
- Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.
- Intense FDG uptake in a benign Hurthle cell adenoma.
- Clinical applications of PET in oncology.
- Update in PET imaging of nonsmall cell lung cancer.
- A spectrum of Doppler waveforms in the carotid and vertebral arteries.
- Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy.
- Colonic uptake of Tc-99m MDP in pseudomembranous colitis.
- Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms.
- The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases fro...
- PET/CT today and tomorrow in veterinary cancer diagnosis and monitoring: fundamentals, early results and future perspectives.
- Not so fast on the thyroidectomy--response to Eloy, et al.
- Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.
- Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins.
- Minor pocket B influences peptide binding, peptide presentation and alloantigenicity of H-2Kb.
- Structural analysis of H-2Kj and H-2Ku.
- Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry.
- Polymorphisms in pockets of major histocompatibility complex class I molecules influence peptide preference.
- Tc-99m MDP uptake in a calcified bladder tumor.
- Discoid lateral meniscus and the frequency of meniscal tears.
- Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.
- NCCN clinical practice guidelines in oncology: prostate cancer.
- The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophagea...
- Clinical utility of PET/CT in lymphoma.
- NCCN clinical practice guidelines in oncology. Anal carcinoma.
- Bone-Seeking Radiopharmaceuticals as Targeted Agents of Osteosarcoma: Samarium-153-EDTMP and Radium-223.
- The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophage...
- Thymic malignancies.
- F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: case series and literature review.
- Novel germline SDHD mutation: diagnosis and implications to the patient.
- Non-small cell lung cancer.
- Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
- Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
- Prognosis and reevaluation of lung cancer by positron emission tomography imaging.
- Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
- Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cance...
- Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
- Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.
- Colon cancer.
- Malignant pleural mesothelioma. Clinical practice guidelines in oncology.
- False-Positive Lesions Mimicking Breast Cancer on FDG PET and PET/CT.
- ABNM Position Statement: Nuclear Medicine Professional Competency and Scope of Practice.
- Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer.
- Effects of injected dose, BMI and scanner type on NECR and image noise in PET imaging.
- What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?
Schools
Mayo Medical School
Doctors Specialties
- Diagnostic Radiology
- Nuclear Medicine
- Radiology
Accepted Insurances
Awards
- Top Doctors:SE Texas
Education
-
Duke University Hospital -
Mayo School of Graduate Medical Education -
Mayo Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1659308716 |
| Last Name Of The Provider | ROHREN |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
|
Dr. Lee A. Myers, MD |
|
|
Dr. David S. Conrow, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcos Calderon, MD |
|
|
Dr. Christopher C. Bathurst, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas P. Haynie III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramesh D. Dhekne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Jing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne C. Kushwaha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen B. Chiang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jody S. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sylvia M. Trumble, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gayle S. Storey, MD |
|
|
Dr. Naga R. Chinapuvvula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harish C. Chintappali, MD |
|
|
Dr. Wayne A. Lindstrom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Trimble, MD |
|
|
Dr. Royce L. Sedotal Sr., MD
This Doctor is OpenDoctor Recommended.
|